Asian Journal of Biomedical and Pharmaceutical Sciences

Reach Us +1 (202) 780-3397

Research Article - Asian Journal of Biomedical and Pharmaceutical Sciences (2024) Volume 14, Issue 106

Natural effect of Oregano essential oils on the survival of Helicobacter pylori: A new therapeutic approach

Kettani Halabi. M*

Research Laboratory in Drug Sciences, Faculty Mohammed VI of Pharmacy, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco

*Corresponding Author:
Kettani Halabi. M
Research Laboratory in Drug Sciences
Faculty Mohammed VI of Pharmacy
Mohammed VI University of Sciences and Health (UM6SS)
Casablanca, Morocco
E-mail: Kettanihalabi@gmail.com

Received: 01-July-2024, Manuscript No. AABPS-24-129055; Editor assigned: 02-July-2024, Pre QC No. AABPS-24-129055(PQ); Reviewed: 15-July-2024, QC No. AABPS-24-129055; Revised: 19-July-2024, Manuscript No. AABPS-24-129055(R); Published: 26-July-2024, DOI: 10.35841/aabps-14.106.241

Citation: Halabi M K. Natural effect of Oregano essential oils on the survival of Helicobacter pylori: A new therapeutic approach. Asian J Biomed Pharm Sci.2024; 14(106):241

Abstract

Helicobacter pylori is an extremely common infection worldwide: more than two thirds of the world's population suffer from it. H. pylori is a bacterium that infects the mucous membrane of the wall of the human stomach. This is often the cause of chronic type B gastritis, gastric ulcers, and gastric cancers. The eradication of this bacterium as a means of prevention and treatment of ulcers and certain stomach cancers is now a solution that natural medicine can implement through a proven phytotherapeutic protocol. And this is an area where essential oils can make a difference. The consequences of this infection depend on the complex interactions that occur between the person who suffers from it and the bacteria: It all depends on the virulence of the bacteria, the genetic constitution of the person, about his age, of a whole set of environmental factors and his eating habits. At present, more or less invasive treatments are content with a very symptomatic and localized approach. Studies have shown that to combat Helicobacter pylori and relieve the symptoms associated with it, it is recommended to ingest natural antibiotic, probiotic and a proton-pump inhibitors (PPIs) treatment. Other studies rather rare propose an approach to stimulate the immunity of the patient and experiment a nutritional approach compatible with the management of the infection and thus better manage the inflammation. Our opinion, which only focuses on recent publications in journals with high-impact, suggests the impact of oregano oil (Origanum compactum) that fight infection with Helicobacter pylori. Findings presented herein could be used to develop novel and alternative preventive and therapeutic strategies aimed to fight Helicobacter pylori infection.

Keywords

Essential oils, Helicobacter pylori, Oregano oil, Phytotherapy, naturals substances.

Introduction

The genus Helicobacter were first detected by J. Robin Warren in 1979 in stomach biopsies from ulcer patients [1]. Helicobacter pylori (H. pylori) is a curved, gram-negative rod, with its characteristic strong urealytic ability, is the gastric helicobacter of humans and is found almost exclusively in the human stomach, which provides the reservoir of infection [2]. Marshall and Warren first proposed the association of H. pylori with gastric or peptic ulcer disease [3]. Gastritis is experienced as sharp or burning pain emanating from the abdomen. Gastric or peptic ulcers are actual lesions in either the mucosa of the stomach (gastric ulcers) or in the uppermost portion of the small intestine (duodenal ulcers) [4]. Severe ulcers can be accompanied by vomiting, bloody stools, or both. The symptoms are worse at night, after eating, or under psychological stress conditions. The second most common cancer in the world is stomach cancer, and most findings suggest that long-term infection with H. pylori is a major contributing factor [5]. The same applies to gastric MALT lymphoma, a rare stomach cancer, is caused by H. pylori infection and is the only cancer which can possibly be cured by antibiotics [6]. The pathogenic properties of this bacterium are due to the ability to survive in the acidic gastric juice and multiply within the mucus, to colonize the gastric mucosa and persist as an extracellular bacterium for several years despite the strong immune responses they trigger [7]. Another protective adaptation of the bacterium is the formation of urease, an enzyme that converts urea into ammonium and bicarbonate, both compounds that can participates in the neutralization of gastric juice. Prominent mucosal inflammation is often evident in the antrum, predisposing patients to hyperacidity and duodenal ulcer disease. Before the bacterium was discovered, psychological stress, spicy foods and high-sugar diets, were considered to be the cause of gastritis and ulcers. Now it appears that these factors merely aggravate the underlying infection [8]. Helicobacter has been in human stomachs for at least 100,000 years. The bacterium is present in the stomachs of more than 60% of adults over 60 years of age and 25% of healthy middle-age adults [9]. These percentages may vary depending on whether one is talking about developed or developing countries. In developing countries, infection occurs early in life; most children are infected by the age of 10, and prevalence remains high (up to 90%) for all adult age groups. In contrast, in developed countries, a progressive increase in prevalence is observed, from a low percentage of infection in those born after 1980 to 40 to 50% infection rates in the older age groups [10]. The modes and routes of transmission of H. pylori from person to person remain to be definitely proven. In the infectious diseases affecting the gastrointestinal tract (chapter 22) of the book " Microbiology: A systemic approach" edition 2018, the authors describe the "family transfer" in helicobacter bacteria as epidemiological evidence for both oral-oral and fecal-oral transmission, with the latter being more likely in developing countries, where sanitation and contaminated water supplies may pose a greater risk [11]. In diagnosis, the urea breath test is a non-invasive method that is sometimes used.

This test is usually recommended when verifying that the organism was eradicated by treatment. Other immunoenzymatic assay and molecular tests on the stool are also available [12, 13]. About one-half of the world's population is colonized by H. pylori. It’s not known what makes some people feel symptoms and get sick, and others do not feel it. It should also not surprise us that the absence of colonization by the bacteria over a short period cannot lead to imbalances and health consequences [14]. Today, there is no treatment to avoid colonization and no effective vaccine for Helicobacter [15]. For symptomatic infection, the best treatment is tetracycline plus metronidazole. Currently, these therapies have numerous drawbacks, mostly due to increasing prevalence of antibiotic resistant strains [16, 17]. Given the very limited action of this treatment, eradication of this bacterium as a means of prevention and treatment of ulcers and certain stomach cancers is now a solution that natural medicine can implement through a proven phytotherapeutic protocol. Hence the interest of to develop novel therapeutic agents against H. pylori infections. A safe and effective method of treatment is the use of essential oils [18, 19]. They fight against infection and relapse. Here are some essential oils that fight the bacteria H. pylori. five plants with maximum effectiveness to know: Origanum vulgare (Oregano oil), Thymus vulgaris (thyme oil), Melaleuca alternifolia (tea tree oil), Cinnamomum zeylanicum (cinnamon oil) and Eugenia caryophyllata (clove oil). We focus in this mini review on the oregano essential oils known as the best remedy against H. pylori infections.

Oregano essential oil (OEO) is considered to be the most effective natural antimicrobial and antioxidant agents [20]. Recent studies have also shown that the OEO is effective as an antioxidant, flavoring agent [21] and retarding the oxidation of lipids [22]; which makes oregano a source of essential oil the most used in the food industry. There are different types of oregano from the genus Origanum: O. vulgare, O. onites L, O. virens, O. majorana L and O. viride representing the Mediterranean region. Carvacrol and thymol are the main antimicrobial, anti-fungal and antioxidant monoterpene phenolic compounds, which account for approximately 85% of OEO [23, 24]. The antimicrobial activity of these compounds is attributed to their lipophilic character. These compounds act as antioxidant agents, retarding lipid oxidation [25]. The antioxidant properties of oregano have been proved to be effective in retarding the process of lipid peroxidation in fatty foods [26]. In addition to the antioxidant and antimicrobial properties of OEO, carvacrol and thymol provide the characteristic flavor and odor. Carvacrol has been found as a potent anti-cancer compound inducing apoptosis in human colon cancer cells [27] and growth inhibition in human cervical cancer cells. Thymol is one of the phenolic compounds of oregano that has a repertoire of pharmacological activities, including anti- inflammatory, anticancer, antioxidant and antimicrobial effects. Recent studies have shown that thymol is responsible for inducing apoptosis in gastric carcinoma cells [28, 29]. There have been reports that toxicity of the OEO constituents were found to be much higher than their therapeutic doses. Although the number of studies on genotoxic effects of OEO constituents is still limited. In bacteria (Table 1), EOs and their components perform a variety of mechanisms targeting different pathways, in particular on the cell membrane [30]. Thymol and carvacrol, active ingredients of oregano, are able to disintegrate the outer membrane of H. pylori, releasing the lipopolysaccharide components, and changing the passive permeability of the cell [31,32].

OE Main constituents Effective against Test method References
O. vulgare Carvacrol, Thymol, Cymenol, Cymene, alpha-Pinene H. pylori, S enteritidis, B. cereus, E. coli, L. monocytegenes, P. aeruginosa, C. albicans, B. subitilis, B. pumilis, S. poona and S. aureus Broth microdilution method, Checkerboard method, Diffusion method, Resazurin microtitre assays, Germ tube inhibition Stamatis et al. 2003; Lesjak et al. 2016; Govaris et al., 2010; Gutierrez et al., 2008; Dimitrijevic et al., 2007; Rosato et al., 2009; Hussain et al., 2011; Pozzatti et al., 2010

Table 1: Oregano Oil essential and its antibacterial activity related to chemical constituents.

In a study published in "phytotherapy research", the author emphasizes that the essential oils examined showed different degrees of antimicrobial activity against the strain H. pylori SS1. He later ascertains that the EOs of S. hortensis, O. vulgare subsp. vulgare and O. vulgare subs hirtum are the most active. despite the significantly low phenol content of the latter. The combination of EO from of S. hortensis and O. vulgare subsp. hirtum in volume ratio 2:1 showed stronger antimicrobial activity against H. pylori [33]. The extracts of Origanum vulgare, Cerastium candidissimum, Chamomilla recutita, Conyza albida, Dittrichia viscosa, Anthemis melanolepis and Stachys alopecuros have been proved active against 15 clinical isolates of H. pylori [34]. According to GC- MS, oils in the mixture were characterized by high content of phenols, with carvacrol as the main carrier of antimicrobial activity.

Conclusion

About half of the world's population is colonized by H. pylori. Oregano essential oils remain an effective alternative to fight against this bacterium. Its action is much greater when it is mixed with other oils rich in phenolic compounds such as S. hortensis, cranberry, basil (Ocimum basilicum) (Shetty and Labbe 1998) or other. It remains to identify the combination that gives the best synergic effect against H. pylori.

References

  1. Steensma DP, Kyle RA, Shampo MA. J. Robin Warren: Helicobacter pylori and peptic ulcer. Mayo Clinic Proceedings. 2016 (Vol. 91, No. 9, pp. e129-e130). Elsevier.
  2. Indexed at, Google Scholar, Cross Ref

  3. Owen RJ. Helicobacter-species classification and identification. British Medi Bulletin. 1998;54(1):17-30.
  4. Indexed at, Google Scholar, Cross Ref

  5. Pai-Dhungat, J. V. (2016). Barry marshall and robin warren: H. pylori in peptic ulcer. J Associa Physicia India, 64(4), 104.
  6. Indexed at, Google Scholar

  7. Sipponen P, Maaroos HI. Chronic gastritis. Scandinav J Gastroenterolo. 2015;50(6):657-67.
  8. Google Scholar

  9. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. New England J Medi. 1991;325(16):1127-31.
  10. Indexed at, Google Scholar, Cross Ref

  11. Asano N, Iijima K, Koike T, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: a review. World J Gastroenterolo: WJG. 2015;21(26):8014.
  12. Indexed at, Google Scholar, Cross Ref

  13. Ghotaslou R, Leylabadlo HE, Nasiri MJ, et al. Risk of gastric cancer in association with Helicobacter pylori different virulence factors: A systematic review and meta-analysis. Microbial Pathogen. 2018;118:214-9.
  14. Indexed at, Google Scholar, Cross Ref

  15. Fahey JW, Stephenson KK, Wallace AJ. Dietary amelioration of helicobacter infection. Nutrit Res. 2015;35(6):461-73.
  16. Indexed at, Google Scholar, Cross Ref

  17. Krejs GJ. Helicobacter pylori and stomach cancer. Acta Medica Austriaca. 2000;27(4):129-30.
  18. Google Scholar

  19. Suerbaum S, Michetti P. Helicobacter pylori infection. New England J Medic. 2002;347(15):1175-86.
  20. Indexed at, Google Scholar, Cross Ref

  21. Tonkic A, Tonkic M, Lehours P, et al. Epidemiology and diagnosis of helicobacter pylori Infection. Helicobacter. 2012;17:1-8.
  22. Indexed at, Google Scholar, Cross Ref

  23. Masoero G, Lombardo L, Della Monica P, et al. Discrepancy between helicobacter pylori stool antigen assay and urea breath test in the detection of Helicobacter pylori infection. Digesti Liver Diseas. 2000;32(4):285-90.
  24. Indexed at, Google Scholar, Cross Ref

  25. Bonamico M, Strappini PM, Bonci E, et al. Evaluation of stool antigen test, PCR on ORAL samples and serology for the noninvasive detection of Helicobacter pylori infection in children. Helicobacter. 2004;9(1):69-76.
  26. Indexed at, Google Scholar, Cross Ref

  27. Schulz C, Schütte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clini Gastroenterolo. 2014;48(6):491-9.
  28. Indexed at, Google Scholar, Cross Ref

  29. Abadi AT. Vaccine against Helicobacter pylori: Inevitable approach. World J Gastroenterolo. 2016;22(11):3150.
  30. Indexed at, Google Scholar, Cross Ref

  31. Peretz A, Paritsky M, Nasser O, et al. Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. J Antibiotic. 2014;67(8):555-7.
  32. Indexed at, Google Scholar, Cross Ref

  33. Harmati M, Gyukity‐Sebestyen E, Dobra G, et al. Binary mixture of Satureja hortensis and Origanum vulgare subsp. hirtum essential oils: in vivo therapeutic efficiency against Helicobacter pylori infection. Helicobacter. 2017;22(2):e12350.
  34. Indexed at, Google Scholar, Cross Ref

  35. Hassan ST, Majerová M, Šudomová M, et al. Antibacterial activity of natural compounds-essential oils. Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 2015;64(6):243-53.
  36. Google Scholar

  37. Cirmi S, Bisignano C, Mandalari G, et al. Anti‐infective potential of citrus bergamia risso et poiteau (bergamot) derivatives: A systematic review. Phytotherapy Research. 2016 Sep;30(9):1404-11.
  38. Indexed at, Google Scholar, Cross Ref

  39. Benavides S, Villalobos Carvajal R, Reyes JE. Physical, mechanical and antibacterial properties of alginate film: Effect of the crosslinking degree and oregano essential oil concentration. J Food Engineer. 2012;110(2):232-9.
  40. Google Scholar

  41. Loizzo MR, Menichini F, Conforti F, et al. Chemical analysis, antioxidant, antiinflammatory and anticholinesterase activities of Origanum ehrenbergii Boiss and Origanum syriacum L. essential oils. Food Chem. 2009;117(1):174-80.
  42. Google Scholar

  43. Handl S, Hellweg P, Khol‐Parisini A, et al. Effect of oregano (O. majorana× O. vulgare) on performance and antioxidative capacity of quails fed a diet rich in ω3 fatty acids. J Animal Physiolo Animal Nutrition. 2008;92(3):242-5.
  44. Indexed at, Google Scholar, Cross Ref

  45. Abbaszadeh S, Sharifzadeh A, Shokri H, et al. Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi. J Mycologie Medi. 2014;24(2):e51-6.
  46. Indexed at, Google Scholar, Cross Ref

  47. Miladi H, Zmantar T, Chaabouni Y, et al. Antibacterial and efflux pump inhibitors of thymol and carvacrol against food-borne pathogens. Microbial Pathogene. 2016;99:95-100.
  48. Indexed at, Google Scholar, Cross Ref

  49. Rodriguez-Garcia I, Silva-Espinoza BA, Ortega-Ramirez LA, et al. Oregano essential oil as an antimicrobial and antioxidant additive in food products. Critical Rev Food Sci Nutri. 2016;56(10):1717-27.
  50. Indexed at, Google Scholar, Cross Ref

  51. Hossain MB, Camphuis G, Aguiló‐Aguayo I, et al. Antioxidant activity guided separation of major polyphenols of marjoram (Origanum majorana L.) using flash chromatography and their identification by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Separa Sci. 2014;37(22):3205-13.
  52. Indexed at, Google Scholar, Cross Ref

  53. Fan K, Li X, Cao Y, et al. Carvacrol inhibits proliferation and induces apoptosis in human colon cancer cells. Anti-Cancer Drug. 2015;26(8):813-23.
  54. Indexed at, Google Scholar, Cross Ref

  55. Kang SH, Kim YS, Kim EK, et al. Anticancer effect of thymol on AGS human gastric carcinoma cells. J Microbiolo Biotechnolo. 2016;26(1):28-37.
  56. Indexed at, Google Scholar, Cross Ref

  57. Günes-Bayir A, Kocyigit A, Kiziltan HS. Effects of thymol, a natural phenolic compound, on human gastric adenocarcinoma cells in vitro. Alterna Therap Health Medic. 2019;25(2):12-21.
  58. Indexed at, Google Scholar

  59. Chouhan S, Sharma K, Guleria S. Antimicrobial activity of some essential oils—present status and future perspectives. Medici. 2017;4(3):58.
  60. Indexed at, Google Scholar, Cross Ref

  61. Ribeiro AR, Diniz PB, Pinheiro MS, et al. Gastroprotective effects of thymol on acute and chronic ulcers in rats: The role of prostaglandins, ATP-sensitive K+ channels, and gastric mucus secretion. Chemico Biolo Interact. 2016;244:121-8.
  62. Indexed at, Google Scholar, Cross Ref

  63. Lesjak M, Simin N, Orcic D, et al. Binary and tertiary mixtures of Satureja hortensis and Origanum vulgare essential oils as potent antimicrobial agents against Helicobacter pylori. Phytothera Res. 2016;30(3):476-84.
  64. Indexed at, Google Scholar, Cross Ref

  65. Stamatis G, Kyriazopoulos P, Golegou S, et al. In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J Ethnopharmacolo. 2003;88(2-3):175-9.
  66. Indexed at, Google Scholar, Cross Ref

  67. Lin YT, Kwon YI, Labbe RG, et al. Inhibition of Helicobacter pylori and associated urease by oregano and cranberry phytochemical synergies. Applied Environ Microbiolo. 2005;71(12):8558-64.
  68. Indexed at, Google Scholar, Cross Ref

Get the App